Pathology News
- July 12, 2024
A mobile laboratory-in-a-van that brings testing services to underserved Connecticut neighborhoods is enabling Yale Pathology of Yale School of Medicine to establish relationships and build trust with community organizations.
- July 11, 2024
A gene mutation that causes human immune defects reveals new biology of antibody responses and may open the door to new autoimmune disease treatments, a Yale-led study has found.
- July 11, 2024
The use of AI to measure immune health could lead to precision medicine tools that assess an individual’s current and future health trajectory, a Yale study finds.
- July 11, 2024Source: Yale Ventures
The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases. In addition to grant funding, Colton Center awardees receive mentorship, access to industry expertise, and feedback on their potential commercialization.
- July 09, 2024
Two genes could serve as a screening mechanism for resistance to immunotherapy in non-small cell lung cancer (NSCLC), though further research is needed.
- July 09, 2024
In a new study, Yale researchers identified a molecule that binds to a disease-associated macrophage migration inhibitory factor (MIF) gene variant. The discovery, they say, could lead to the development of a new generation of precision medicine-based therapies that address diverse autoimmune and inflammatory conditions.
- July 08, 2024Source: The Cancer Letter
The workshop, hosted by Yale Cancer Center and Smilow Cancer Hospital June 12 – 13, was held in commemoration of the 20th anniversary of the discovery of EGFR mutation in lung cancer, which launched the era of personalized medicine in advanced non-small cell lung cancer, leading to a dramatic shift in treatment.
- July 05, 2024Source: The Cancer Letter
May 2024 marked the 20th anniversary of the publication of papers on the role of EGFR mutation in lung cancer. This is a seminal event that changed the history of this disease and that can be traced back to one reason why cancer mortality has been declining in the United States.
- July 01, 2024
Pei Hui, MD, PhD, Professor of Pathology and of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, has been chosen as President-Elect of the International Society of Gynecologic Pathologists.